An analysis of 0.1% AmBisome eye drops for keratomycosis

An analysis of 0.1% AmBisome eye drops for keratomycosis - An analysis of 0.1% AmBisome eye drops for keratomycosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027686

Enrollment

Registered

2017-08-01

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratomycosis

Interventions

0.1% AmBisome eye drops

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A case of keratomycosis

Exclusion criteria

Exclusion criteria: A patient with an allelgies for AmBisome Infants and expectant mother

Design outcomes

Primary

Measure	Time frame
Symptom Corneal epithelial defect Corneal stromal opacity Uveitis conjunctive injection and edema	—

Countries

Japan

Contacts

Public ContactTatsuro Miyamoto

Institute of Biomedical Sciences, Tokushima University Graduate School Department of Ophthalmology

miyatatsu@tokushima-u.ac.jp088-633-7163

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026